World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
99
Citations
47733
World Ranking
427
National Ranking
197

Medicine

D-Index
99
Citations
48361
World Ranking
8445
National Ranking
4366

Overview

Lloyd Mayer was affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focused on medical and immunological fields, with a significant number of publications contributing to the study of immune responses, allergy, and gastrointestinal diseases.

The main field of study for Mayer was medicine, with 13 publications recorded. Within this broad domain, significant subfields included:

  • Immunology and Allergy
  • Immunology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Epidemiology

Their work touched on several main topics such as:

  • Food Allergy and Anaphylaxis Research
  • Cell Adhesion Molecules Research
  • Immunotherapy and Immune Responses
  • Monoclonal and Polyclonal Antibodies Research
  • Diverticular Disease and Complications
  • Biliary and Gastrointestinal Fistulas
  • Anorectal Disease Treatments and Outcomes

Lloyd Mayer published multiple papers, some noteworthy recent publications include:

  • A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease (2022, Gastroenterology)
  • Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial (2021, UNC Libraries)
  • The natural history of milk allergy in an observational cohort (2020, UNC Libraries)
  • Enteroendocrine cells express functional Toll-like receptors (2020, UNC Libraries)
  • A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis (2021, UNC Libraries)

The venues where Mayer frequently published were:

  • UNC Libraries (6 publications)
  • Gastroenterology (1 publication)

Mayer collaborated often with several researchers, frequently coauthoring with:

  • William J. Sandborn
  • Stephen B. Hanauer
  • Robert A. Wood
  • Scott H. Sicherer
  • Brian P. Vickery

Best Publications

  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer

  • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

    S. R. Targan;S. B. Hanauer;S. J. H. Van Deventer;L. Mayer

  • Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

    Beth Levine;Jill Kalman;Lloyd Mayer;Howard M. Fillit

  • Infliximab for the treatment of fistulas in patients with Crohn's disease.

    D.H. Present;P.J. Rutgeerts;S.R. Targan;S.B. Hanauer

  • Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

    Paul Rutgeerts;G D'Haens;S Targan;E Vasiliauskas

  • Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

    Paul Rutgeerts;Brian G. Feagan;Gary R. Lichtenstein;Lloyd F. Mayer

  • Anti-interleukin-12 antibody for active Crohn's disease

    Peter J. Mannon;Ivan J. Fuss;Lloyd Mayer;Charles O. Elson

  • Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

    Stephen B Hanauer;Carrie L Wagner;Mohan Bala;Lloyd Mayer

  • Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance

    Bo Huang;Jie Zhao;Hongxing Li;Kai-Li He

  • Evidence for function of Ia molecules on gut epithelial cells in man.

    Lloyd Mayer;Robert Shlien

  • The incidence and management of infusion reactions to infliximab: a large center experience

    Adam Cheifetz;Michelle Smedley;Sara Martin;Monica Reiter

  • Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals

    Meimei Shan;Maurizio Gentile;John R. Yeiser;A. Cooper Walland

  • Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

    Bruce E. Sands;William J. Tremaine;William J. Sandborn;Paul J. Rutgeerts

  • Oral tolerance and its relation to food hypersensitivities.

    Mirna Chehade;Lloyd Mayer

  • The natural history of egg allergy in an observational cohort.

    Robert A. Wood;Scott H. Sicherer;Brian P. Vickery;Stacie M. Jones

  • Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial

    William J Sandborn;Daniel H Present;Kim L Isaacs;Douglas C Wolf

  • Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases

    Zaruhi Hovhannisyan;Jacquelyn Treatman;Dan R. Littman;Lloyd Mayer

  • Antigen processing and presentation by intestinal epithelial cells – polarity and complexity

    Robert M Hershberg;Lloyd F Mayer

  • Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut

    Natalia Shulzhenko;Andrey Morgun;Andrey Morgun;William Hsiao;Michele Battle

  • Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

    James F. Marion;Jerome D. Waye;Daniel H. Present;Yuriy Israel

Frequent Co-Authors

Maria T. Abreu
Maria T. Abreu University of Miami
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Jay C. Unkeless
Jay C. Unkeless Icahn School of Medicine at Mount Sinai
Huabao Xiong
Huabao Xiong Icahn School of Medicine at Mount Sinai
Matthieu Allez
Matthieu Allez Université Paris Cité
Charlotte Cunningham-Rundles
Charlotte Cunningham-Rundles Icahn School of Medicine at Mount Sinai
William J. Sandborn
William J. Sandborn University of California, San Diego
Hugh A. Sampson
Hugh A. Sampson Icahn School of Medicine at Mount Sinai
Stephan R. Targan
Stephan R. Targan Cedars-Sinai Medical Center
M. Cecilia Berin
M. Cecilia Berin Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing a career in microbiology or related healthcare fields, several online healthcare degrees that pay well offer excellent opportunities. These programs provide flexible paths for students to enter high-demand sectors such as medical research, clinical laboratory science, and healthcare administration.

Public health is another complementary area to microbiology. Many students consider enrolling in online public health masters programs easy to get into, which can enhance understanding of disease prevention, epidemiology, and community health. These degrees typically open doors to impactful careers in health policy and management.

A specialized but rewarding career option is becoming a child life specialist. This role focuses on supporting children through medical treatment emotionally and psychologically. Learning about the child life specialists salary helps prospective students gauge the financial benefits of this profession.

Accessibility is another important consideration for many students. There are also valuable degrees for felons that enable individuals with records to pursue reputable education and successful career pathways, particularly in healthcare and the sciences.

Best Scientists Citing Lloyd Mayer

Recently Published Articles